ONYX
Inventory Status:
Availability: Available
$75.00
Strict Regulatory Notice: This agent is synthesized strictly for laboratory-based research and analytical purposes. It is not intended for human or veterinary use, nor for medical, household, or cosmetic applications. Please review our Terms of Service thoroughly before finalizing your acquisition.
Composition: Each mL of sterile solution contains:
Active Ingredients:
RU58841 5%……………(50mg/ml)
Finasteride 0.5%………..(5mg/ml)
Dutasteride 0.3%………..(3mg/ml)
Minoxidil 5%…………….(50mg/ml)
Hyaluronic acid 0.01%…..(0.1mg/ml)
Tretinoin: 0.1%…………..(1mg/ml)
Inactive Ingredients: Ethyl Alcohol, Propylene Glycol
Availability: Available
Guaranteed Safe Checkout:
Key Specifications
| Parameter | Specification / Details |
|---|---|
| Primary Compound Name | ONYX Topical Solution |
| Active Constituent 1 | RU58841 (5%): Non-steroidal antiandrogen |
| Active Constituent 2 | Finasteride (0.5%): Type II 5ɑ-reductase inhibitor |
| Active Constituent 3 | Dutasteride (0.3%): Type I & II 5ɑ-reductase inhibitor |
| Active Constituent 4 | Minoxidil (5%): Potassium channel opener / Vasodilator |
| Active Constituent 5 | Tretinoin (0.1%): Retinoid / Cell-turnover accelerator |
| Active Constituent 6 | Hyaluronic Acid (0.01%): Glycosaminoglycan / Humectant |
| Physical Appearance | Clear to slightly yellow liquid solution |
| Solubility Profile | Solubilized in an alcohol/glycol carrier (Ethyl Alcohol & Propylene Glycol) |
| Tested Purity | Individual constituents ≥98% via HPLC |
| Total Active (per 30mL) | 1,500mg RU / 150mg Fin / 90mg Dutasteride / 1,500mg Minox / 30mg Tret / 3mg HA |
| Inactive Ingredients | Ethyl Alcohol, Propylene Glycol |
| Storage Guidelines | Store at 20°C to 25°C. Extremely light-sensitive due to Tretinoin; keep in amber/opaque containers. |
| Estimated Shelf Life | 12 to 18 months. Tretinoin and Dutasteride may degrade faster if exposed to UV light or oxygen. |
| Terms of Application | For laboratory research purposes only. Investigated for the synergistic effects of localized androgen receptor blockade (RU58841), dual-isoenzyme DHT suppression (Finasteride/Dutasteride), and enhanced follicular vasodilation (Minoxidil). The inclusion of Tretinoin is studied for its ability to increase stratum corneum permeability and accelerate epithelial turnover, while Hyaluronic Acid is evaluated for its humectant properties in counteracting carrier-induced desiccation in ex-vivo skin models. |
Foundational Scientific Overview
Onyx is a proprietary musculoskeletal research compound developed for the rigorous study of osteoblast genesis, bone mineral density (BMD) modulation, and connective tissue extracellular matrix remodeling. It serves researchers examining cellular pathways related to structural fortification, collagen synthesis, and the mitigation of osteoclast-mediated bone resorption.
At 4 Amino Labs, we provide this highly purified complex to ensure experimental reproducibility. By maintaining rigorous measurement standards, we provide the consistency required for longitudinal data integrity.
Scientific Literature Reference: The biochemical control of osteoblast function and the synthesis of connective tissue matrices are highly established in musculoskeletal literature. See: Harada, S., & Rodan, G. A. (2003). “Control of osteoblast function and regulation of bone mass.” Nature, 423(6937), 349-355.
Analytical Composition & Purity Standards
- Chemical Formula: Proprietary Osteogenic Polypeptide Matrix
- Physical State: Lyophilized Solid / Aqueous Solution
Our Onyx blend undergoes a multifaceted verification process. Each batch is subjected to independent High-Performance Liquid Chromatography (HPLC) to verify the precise structural integrity, ensuring a purity threshold of ≥ 99%.
Investigational Pathways
Researchers utilizing Onyx typically focus on the following biochemical mechanisms:
- Osteoblast Proliferation: Evaluating the compound’s influence on the mitotic rate of bone-forming cells in-vitro.
- Collagen Deposition: Observing the upregulation of Type I collagen synthesis in fibroblast and osteoblast co-cultures.
- Osteoclast Inhibition: Mapping the reduction of bone-resorbing cellular activity under induced osteoporotic models.
- Mineralization Cascades: Investigating the localized precipitation of calcium and phosphate in tissue assays.
Laboratory Handling & Stability Protocol
To maintain the molecular integrity of Onyx, the following storage parameters are recommended:
- Thermal Regulation: Store in a strictly controlled, refrigerated, and desiccated environment.
- Photostability: Protect from direct UV exposure; storage in an opaque container is advised.
- Contamination Control: Utilize sterilized instruments and work within a laminar flow hood where possible.
Compliance & Safety Disclaimer
This substance is provided exclusively for in-vitro laboratory research and pre-clinical developmental testing. 4 Amino Lab does not condone or authorize the use of this product in any clinical setting or for personal consumption. Misuse of laboratory chemicals carries significant health risks. By purchasing, the researcher acknowledges the inherent risks and confirms they possess the necessary equipment and expertise to handle these materials safely.
